The Pricing Problem at the Heart of Every IPO
Every IPO begins with the same fundamental challenge: how do you set a fair price for a company that has never traded publicly before? There is no ticker history, no consensus analyst estimate, no prior earnings call to benchmark against. There is only a business, a set of financials, and a market of potential buyers who all have different opinions about what the company is worth.
The answer is a structured valuation process led by the underwriting banks. Before a deal prices -- before a single retail investor can buy a share -- teams of investment bankers, equity research analysts, and institutional sales professionals spend weeks building financial models, running roadshow meetings, and synthesizing investor demand to arrive at an offering price that can clear the market.
Understanding how that process works is not just academic. The valuation methods underwriters use directly shape the price you pay, the premium baked into the offering, and the return potential available after the deal prices. Retail investors who understand IPO valuation are better equipped to judge whether a deal is attractively priced, fairly valued, or set up to disappoint -- and that judgment is the foundation of any disciplined IPO investing approach.
This guide covers the five core valuation methods underwriters use, how they interact in practice, and what retail investors should take away from each.
Why Underwriters Use Multiple Methods
No single valuation method is authoritative in isolation. Each has blind spots, and each answers a slightly different version of the question "what is this company worth." Investment banks run multiple methods in parallel precisely because the range of outputs across methods tells you something important: when they converge, the valuation is probably grounded; when they diverge sharply, the pricing involves a significant judgment call that deserves scrutiny.
The final offering price is not a mechanical output of these models. It is a negotiated outcome informed by the models, shaped by institutional demand observed during the roadshow, and influenced by competitive dynamics among the underwriting syndicate. Understanding the methods helps you reverse-engineer what assumptions were embedded in the final number -- and whether you agree with them.
Method 1: Comparable Company Analysis ("Comps")
Comparable company analysis -- universally called "comps" on Wall Street -- is typically the first and most influential valuation method in any IPO. The logic is straightforward: if similar public companies trade at certain multiples of their earnings, revenue, or EBITDA, then the IPO candidate should trade at a similar multiple, adjusted for its specific characteristics.
How It Works
The banker's team selects a peer group of publicly traded companies that share the IPO candidate's industry, business model, growth profile, and financial characteristics. They then calculate trading multiples for each peer -- commonly enterprise value to revenue (EV/Revenue), enterprise value to EBITDA (EV/EBITDA), or price-to-earnings (P/E) -- and apply the median or a range of those multiples to the IPO candidate's own metrics.
For a high-growth software company generating $200 million in annual recurring revenue, the team might look at comparable SaaS peers trading at 8x to 12x forward revenue and derive an implied enterprise value of $1.6 billion to $2.4 billion. The IPO price per share follows from that enterprise value adjusted for debt, cash, and share count.
What to Watch
The peer group selection is where the most judgment -- and the most potential for bias -- enters the analysis. Banks have an incentive to select comparables that support a higher valuation (which makes the deal easier to market and maximizes the fees tied to proceeds). Retail investors should ask whether the selected comps are genuinely similar businesses or whether the list cherry-picks the most richly valued names in the sector.
The choice of metric also matters. For pre-profit companies, revenue multiples are unavoidable, but they embed aggressive assumptions about future margins. A company valued at 15x revenue with a 30% gross margin is a very different investment than one at 15x revenue with a 70% gross margin -- even though the multiple looks identical.
Method 2: Precedent Transaction Analysis
Where comps look at how similar companies trade in the public market today, precedent transaction analysis looks at what acquirers have historically paid to buy comparable companies outright. The logic: M&A buyers pay a control premium above market prices, so transaction multiples set a ceiling on what the public market might ultimately be willing to pay.
How It Works
Bankers compile a database of completed mergers and acquisitions in the relevant sector, typically going back five to ten years. For each deal, they calculate the acquisition multiple -- the price paid relative to the target's revenue, EBITDA, or earnings. These transaction multiples are almost always higher than public market trading multiples because they reflect the premium a strategic buyer pays for control, synergies, and competitive positioning.
Applied to an IPO, precedent transactions provide an upper-bound reference: if comparable companies have been acquired at 14x to 18x EBITDA, the IPO candidate's valuation ceiling likely sits somewhere in that range.
What to Watch
Precedent transactions can be misleading when market conditions have shifted significantly. A deal struck at a 15x multiple during peak 2021 valuations says little about what the same type of business can command in a more normalized rate environment. Always check the vintage of the transactions in the precedent set -- stale comps from different market cycles can produce inflated implied values.
For retail investors reviewing a prospectus, the underwriters' discussion of comparable transactions in the registration statement's "Use of Proceeds" and underwriting sections offers a window into the valuation narrative being told to institutional buyers. This connects directly to the analysis laid out in our SEC S-1 filing guide for retail investors, which covers where to find these disclosures in the document.
Method 3: Discounted Cash Flow Analysis (DCF)
The discounted cash flow model is the most theoretically rigorous valuation approach and, in practice, the most sensitive to assumptions. A DCF values a company based on the present value of its expected future free cash flows, discounted back at a rate that reflects the risk of those cash flows.
How It Works
Bankers build a multi-year projection model -- often extending five to ten years -- forecasting the company's revenue growth, operating margins, capital expenditure requirements, and working capital dynamics. At the end of the projection period, they calculate a terminal value (the estimated value of all cash flows beyond the forecast window) and discount everything back to today at the weighted average cost of capital (WACC).
For a rapidly growing company with minimal current cash flow, the DCF is dominated by the terminal value -- which means the output is extraordinarily sensitive to the assumed long-term growth rate and discount rate. A 1% change in the terminal growth assumption can shift the implied valuation by 20% or more.
What to Watch
The DCF is sometimes called a "garbage in, garbage out" model because its output is only as credible as its inputs. When reviewing an IPO, ask whether management's revenue projections in the S-1 are consistent with the company's own historical growth trajectory. Aggressive extrapolation of a recent acceleration -- with no acknowledgment that growth typically decelerates as companies scale -- is a warning sign embedded in many pre-IPO models.
For pre-revenue or early-revenue businesses (common in biotech and deep tech IPOs), DCF analysis is almost entirely speculative. In those cases, the model is less a valuation tool and more a narrative device for communicating management's long-term vision to potential investors. Our IPO first-day performance guide covers how market conditions and investor sentiment affect whether optimistic DCF narratives get rewarded or punished at the open.
Method 4: Leveraged Buyout Analysis (LBO)
The leveraged buyout model is less commonly associated with IPO pricing but is used by banks -- particularly when taking mature, cash-generative businesses public -- as a floor-value reference. An LBO model asks: what is the maximum price a financial sponsor (private equity firm) would pay to acquire this business if the acquisition were financed primarily with debt?
How It Works
The model assumes a hypothetical transaction in which a PE buyer acquires the company using a mix of debt and equity, operates it for five years, and then sells at a market multiple. Working backward from the target return (typically 20% to 25% IRR for institutional PE), the model solves for the maximum entry price a sponsor could pay and still achieve their required return.
For IPO purposes, the LBO value represents a theoretical floor: if the public market values the company below what a financial sponsor would pay in a leveraged buyout, private equity capital would theoretically step in and take the company private. In practice, this analysis is most relevant for profitable companies with stable cash flows -- the types of businesses where debt financing is realistic.
What to Watch
For high-growth, pre-profit companies (which represent the majority of tech IPOs), the LBO analysis is largely irrelevant -- these businesses cannot support the debt loads required for a leveraged buyout. If you see an LBO reference in the underwriters' valuation discussion for a money-losing startup, treat it with skepticism. The method is being deployed for comprehensiveness, not because it meaningfully constrains the valuation.
Method 5: Sum-of-the-Parts Analysis
For conglomerates, holding companies, or businesses with multiple distinct operating segments, underwriters often supplement the above methods with a sum-of-the-parts (SOTP) analysis. Rather than valuing the company as a single entity, SOTP assigns a separate multiple to each business segment and aggregates the results.
How It Works
Consider a company with three divisions: a high-growth cloud software business, a mature professional services arm, and an early-stage consumer hardware segment. Each of those businesses would trade at dramatically different multiples if it were a standalone public company. SOTP applies segment-appropriate multiples to each and adds up the implied values.
SOTP can reveal a "conglomerate discount" -- situations where the market values the consolidated entity at less than the sum of its parts because investors can't get pure-play exposure to the fastest-growing segments. In those cases, the IPO narrative often centers on the plan to separate or monetize undervalued divisions.
What to Watch
SOTP analysis is only as credible as the segment allocation. Companies have wide latitude in how they assign shared costs across segments, and generous allocation of overhead to slower-growing divisions can make the high-growth segment look better than it is. If you're evaluating a multi-segment IPO, dig into the segment accounting methodology in the S-1 footnotes.
How the Book-Building Process Translates Valuation to Price
With valuation models in hand, the underwriting team launches the roadshow -- a two-week intensive process in which management and the lead banker present to institutional investors: mutual funds, hedge funds, sovereign wealth funds, and insurance companies. Each institutional investor that wants to participate in the deal submits an "indication of interest" -- a non-binding order specifying the number of shares they want and, in many cases, the price they're willing to pay.
The lead underwriter aggregates these orders into a book -- essentially a demand schedule showing how many shares institutional investors want at various price points. This book is confidential, but its shape directly determines where the deal prices. A heavily oversubscribed book (far more demand than supply) typically results in pricing at or above the top of the marketed range. A soft book leads to pricing at or below the midpoint, or in some cases a postponed or withdrawn deal.
Retail investors rarely see the book, but its signals are visible. When you observe that an offering has raised its price range mid-roadshow, you are seeing evidence of strong institutional demand. When you see a deal price at the low end of its range or get pulled entirely, you are observing the opposite.
What the Final Price Tells You
The final IPO price is not a neutral outcome of efficient valuation -- it is a price set to balance multiple competing interests. The company wants to maximize proceeds. Underwriters want a deal that clears the market cleanly and trades up modestly on day one (first-day pops are good for their institutional clients who received allocations). Institutional investors want to buy at a discount to fair value to ensure returns.
The result is systematic underpricing: on average, IPOs price below what the market is willing to pay on day one. The "pop" is not accidental -- it is a feature of the process that rewards institutional allocatees at the expense of the issuer and, indirectly, retail buyers who must pay the post-pop open price.
Understanding this dynamic is why the lock-up expiration period often represents a more attractive entry point for retail investors than the IPO itself: the supply event forces temporary price weakness that is unrelated to fundamental value, creating a structural buying opportunity that was not available on day one.
Putting It Together: How to Use This as a Retail Investor
You will not receive a copy of the underwriters' valuation deck. But the S-1 filing discloses the comparable company set the underwriters reference, the IPO price, and the financial projections management has shared publicly. Armed with that information, you can run a rough version of the comps analysis yourself.
Find three to five publicly traded companies that genuinely resemble the IPO candidate. Calculate their EV/Revenue and EV/EBITDA multiples. Apply those multiples to the IPO candidate's current and forward metrics. Compare your implied range to the offering price. If the offering price sits at or above the 75th percentile of your comp range with no clear quality premium to justify it, you are probably being asked to pay for optimism rather than fundamentals.
That check alone will not predict short-term price action -- markets can stay irrational for longer than any model suggests. But it is the starting point for understanding whether you are buying a business at a price that has some margin of safety, or buying a story at a price that requires everything to go right.
IPO.ai aggregates this kind of fundamental valuation context alongside real-time pricing data, S-1 analysis, and lock-up calendar signals -- so you can apply these frameworks at scale, across every active deal in the pipeline, without building your own models from scratch.